Terns Pharmaceuticals, Inc. (TERN)
52.78
+0.06
(+0.11%)
USD |
NASDAQ |
Apr 06, 16:00
52.73
-0.05
(-0.09%)
Pre-Market: 09:20
Terns Pharmaceuticals Shareholders Equity (Quarterly) : 1.007B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Corcept Therapeutics, Inc. | 647.80M |
| Cogent Biosciences, Inc. | 636.37M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| ADMA Biologics, Inc. | 477.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Total Liabilities (Quarterly) | 18.73M |
| Debt to Equity Ratio | 0.0009 |
| Current Ratio | 62.41 |
| Net Debt Paydown Yield | 0.00% |